Lars I Eriksson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lars I Eriksson

Showing results (81-90 of 90) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 90 results.

Clinical & Translational Immunology|July 14, 2021

SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisationJohn Tyler Sandberg, Renata Varnaitė, Wanda Christ, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2023

Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional AnomaliesTobias Kammann, Jean-Baptiste Gorin, Tiphaine Parrot, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 22, 2021

Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severityEgle Kvedaraite, Laura Hertwig, Indranil Sinha, et al.

Science Immunology|August 23, 2020

Natural killer cell immunotypes related to COVID-19 disease severityChristopher Maucourant, Iva Filipovic, Andrea Ponzetta, et al.

Cell|September 27, 2020

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19Takuya Sekine, André Perez-Potti, Olga Rivera-Ballesteros, et al.

Respiratory Research|February 24, 2023

Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumoniaLaura M Palma Medina, Haris Babačić, Majda Dzidic, et al.

Anesthesia and Analgesia|October 11, 2018

Best Practices for Postoperative Brain Health: Recommendations From the Fifth International Perioperative Neurotoxicity Working GroupMiles Berger, Katie J Schenning, Charles H Brown, et al.

European Journal of Immunology|November 27, 2021

COVID-19-specific metabolic imprint yields insights into multiorgan system perturbationsMartin Cornillet, Benedikt Strunz, Olav Rooyackers, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 22, 2021

High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19Magda Lourda, Majda Dzidic, Laura Hertwig, et al.

Scandinavian Journal of Immunology|June 2, 2022

The Karolinska KI/K COVID-19 Immune Atlas: An open resource for immunological research and educational purposesHans-Gustaf Ljunggren, Eivind Heggernes Ask, Martin Cornillet, et al.

Pageof 9

Search research articles

Showing results (81-90 of 90) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 90 results.

Clinical & Translational Immunology|July 14, 2021

SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisationJohn Tyler Sandberg, Renata Varnaitė, Wanda Christ, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2023

Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional AnomaliesTobias Kammann, Jean-Baptiste Gorin, Tiphaine Parrot, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 22, 2021

Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severityEgle Kvedaraite, Laura Hertwig, Indranil Sinha, et al.

Science Immunology|August 23, 2020

Natural killer cell immunotypes related to COVID-19 disease severityChristopher Maucourant, Iva Filipovic, Andrea Ponzetta, et al.

Cell|September 27, 2020

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19Takuya Sekine, André Perez-Potti, Olga Rivera-Ballesteros, et al.

Respiratory Research|February 24, 2023

Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumoniaLaura M Palma Medina, Haris Babačić, Majda Dzidic, et al.

Anesthesia and Analgesia|October 11, 2018

Best Practices for Postoperative Brain Health: Recommendations From the Fifth International Perioperative Neurotoxicity Working GroupMiles Berger, Katie J Schenning, Charles H Brown, et al.

European Journal of Immunology|November 27, 2021

COVID-19-specific metabolic imprint yields insights into multiorgan system perturbationsMartin Cornillet, Benedikt Strunz, Olav Rooyackers, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 22, 2021

High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19Magda Lourda, Majda Dzidic, Laura Hertwig, et al.

Scandinavian Journal of Immunology|June 2, 2022

The Karolinska KI/K COVID-19 Immune Atlas: An open resource for immunological research and educational purposesHans-Gustaf Ljunggren, Eivind Heggernes Ask, Martin Cornillet, et al.

Pageof 9